Stem cell therapies benefit Alport syndrome

Journal of the American Society of Nephrology

Volumn 20, Issue 11, 2009, Pages 2359-2370

  LeBleu, Valerie ^a   Sugimoto, Hikaru ^a   Mundel, Thomas M ^a   Gerami Naini, Behzad ^a   Finan, Elizabeth ^a   Miller, Caroline A ^b   Gattone II, Vincent H ^b   Lu, Lingge ^a   Shield III, Charles F ^c   Folkman, Judah ^d   Kalluri, Raghu ^a,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4;

ALPORT SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GLOMERULUS BASEMENT MEMBRANE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

ANIMALS; AUTOANTIGENS; BONE MARROW CELLS; COLLAGEN TYPE IV; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEPHRITIS, HEREDITARY; STEM CELL TRANSPLANTATION;

EID: 72049083762     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009010123     Document Type: Article

References (18)

1. Kashtan CE: Alport syndrome: An inherited disorder of renal, ocular, and cochlear basement membranes. Medicine (Baltimore) 78: 338-360, 1999
2. Kalluri R, Cosgrove D: Assembly of type IV collagen: Insights from alpha3(IV) collagen-deficient mice. J Biol Chem 275: 12719-12724, 2000 (Pubitemid 30241423)
3. Miner JH, Sanes JR: Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): Implications for Alport syndrome. J Cell Biol 135: 1403-1413, 1996
4. Hudson BG, Reeders ST, Tryggvason K: Type IV collagen: Structure, gene organization, and role in human diseases - Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J Biol Chem 268: 26033-26036, 1993 (Pubitemid 23361657)
5. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG: Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 348: 2543-2556, 2003 (Pubitemid 36706542)
6. Kalluri R: Basement membranes: Structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3: 422-433, 2003
7. LeBleu VS, Macdonald B, Kalluri R: Structure and function of basement membranes. Exp Biol Med (Maywood) 232: 1121-1129, 2007
8. Cosgrove D, Meehan DT, Grunkemeyer JA, Kornak JM, Sayers R, Hunter WJ, Samuelson GC: Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome. Genes Dev 10: 2981-2992, 1996 (Pubitemid 26412525)
9. Cosgrove D, Kalluri R, Miner JH, Segal Y, Borza DB: Choosing a mouse model to study the molecular pathobiology of Alport glomerulonephritis. Kidney Int 71: 615-618, 2007 (Pubitemid 46494562)
10. Kang JS, Wang XP, Miner JH, Morello R, Sado Y, Abrahamson DR, Borza DB: Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice. J Am Soc Nephrol 17: 1962-1969, 2006
11. Sugimoto H, Mundel TM, Sund M, Xie L, Cosgrove D, Kalluri R: Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc Natl Acad Sci U S A 103: 7321-7326, 2006 (Pubitemid 43727831)
12. Prodromidi EI, Poulsom R, Jeffery R, Roufosse CA, Pollard PJ, Pusey CD, Cook HT: Bone marrow derived-cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells 24: 2448-2455, 2006 (Pubitemid 44674305)
13. Katayama K, Kawano M, Naito I, Ishikawa H, Sado Y, Asakawa N, Murata T, Oosugi K, Kiyohara M, Ishikawa E, Ito M, Nomura S: Irradiation prolongs survival of Alport mice. J Am Soc Nephrol 19: 1692-1700, 2008
14. Ninichuk V, Gross O, Segerer S, Hoffmann R, Radomska E, Buchstaller A, Huss R, Akis N, Schlöndorff D, Anders HJ: Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int 70: 121-129, 2006 (Pubitemid 44000128)
15. Gross O, Borza DB, Anders HJ, Licht C, Weber M, Segerer S, Torra R, Gubler MC, Heidet L, Harvey S, Cosgrove D, Lees G, Kashtan C, Gregory M, Savige J, Ding J, Thorner P, Abrahamson DR, Antignac C, Tryggvason K, Hudson B, Miner JH: Stem cell therapy for Alport syndrome: The hope beyond the hype. Nephrol Dial Transplant 24: 731-734, 2009
16. LeBleu V, Sugimoto H, Miller CA, Gattone VH 2nd, Kalluri R: Lymphocytes are dispensable for glomerulonephritis but required for renal interstitial fibrosis in matrix defect induced Alport renal disease. Lab Invest 88: 284-292, 2008 (Pubitemid 351311280)
17. Soutter AD, Ellenbogen J, Folkman J: Splenosis is regulated by a circulating factor. J Pediatr Surg 29: 1076-1079, 1994 (Pubitemid 24265650)
18. Mundel P, Reiser J, Zúñiga Mejía Borja A, Pavenstädt H, Davidson GR, Kriz W, Zeller R: Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236: 248-258, 1997 (Pubitemid 27452369)